IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ridgeback Capital Investments L.P.

Q4 2012 Holdings

Filed 2014-05-15 | 2 holdings | $34.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Celldex Therapeutics IncCommon Stock15117B103$25.5K3,804,64674.6%
Ironwood Pharmaceuticals Inc(IRWD)Common Stock46333X108$8.7K784,38125.4%